CURRICULUM VITAE
OF
JEREMY JONATHAN OWEN HEROD
September 2006
A 43yr old honours graduate from the University of Birmingham Medical School. Completed training in
Obstetrics and Gynaecology in the West Midlands before undergoing sub-specialty training in
Gynaecological Oncology at St Bartholomew’s and The Royal Marsden Hospitals, London.
Currently working as Consultant Gynaecological Surgeon and Oncologist at Liverpool Women’s NHS
Trust – Appointed 1st April 1999
Certificate of Completion of Specialist Training
Feb 1997
Certificate of Completion of Sub-specialty Training in Gynaecological Oncology
Jan 1999
Registration as Recognised Colposcopist and Trainer – BSCCP
Sep1997
RCOG: Member of National Trainees Committee
1995 – 1997
RCOG: Member of working party to consider advance training in O&G
1997
Chairman West Midlands Trainees Committee
1995-1997
Birmingham and Midlands Obstetrics & Gynaecological Society – Members rep.
1997
Bertha Singer Memorial Scholarship
1984
Young Oncologist Travel Award – American Radium Society
1995
Lindsay Park Memorial Medal
1995
Local Representative – North of England O&G Society
1999 – 2005
Clinical Sub-Dean – Liverpool Women’s Hospital
2000 – 2003
Member of Advisory Board of Ovacome (Ovarian Cancer Charity)
1999 –
Lead Clinician for Colposcopy – Liverpool Women’s Hospital
1999 –
Chairman of British Surgical Gynaecological Oncology Group
2001 –
Spokesperson for RCOG on Gynaecological Oncology
2005 -
Author of 19 publications in peer-reviewed journals and 11 chapters. Presenter of over 40 lectures at
national and international meetings including invitational lectures to the Portuguese Medical Association,
the British Oncology Data Managers Association and the RCOG. Presentations also given at the FIGO
world conference, IGCS, ESGO, BGCS, BSCCP, British Congress of Obstetrics & Gynaecology, Blair Bell
Research Society and BOA/BOSA
PERSONAL DETAILS:
Name:
Jeremy Jonathan Owen HEROD
Address:
22School Lane
Bidston Village
Prenton
Wirral
CH43 7RG
Telephone No:
Home
0151 653 4707
Work
0151 702 4003
Nationality:
British
Date of Birth:
2nd June 1963
Age:
43yrs
UNIVERSITY EDUCATION:
University of Birmingham Medical School
1981 – 1987
BSc. Honours in Physiology ( 2:1)
1984
MBChB. with Honours
1987
Honours in:
Anatomy, Biochemistry, Physiology
Pharmacology, Pathology (2), Therapeutics
Obstetrics & Gynaecology, Paediatrics
POSTGRADUATE QUALIFICATIONS:
Diploma of Royal College of Obstetricians & Gynaecologists
1990
Membership of Royal College of Obstetricians & Gynaecologists
1993
Advanced Life Support Certificate
1996
Certificate of Completion of Specialist Training
1997
Certificate of Completion of Subspecialty Training – Gynaecological Oncology
1999
CURRENT POST:
Consultant Gynaecological Surgeon and Oncologist – Liverpool Women’s Hospital
Clinical Advisor – North West Regional Cervical Screening Programme Quality Assurance
Reference Centre
AWARDS AND PRIZES:
Awarded the “Bertha Singer Memorial Scholarship” in July 1984 by the University of Birmingham. This
award enabled me to continue work commenced as part of my studies for the intercalated degree in
physiology.
Awarded the `Young Oncologist Travel Award in Gynaecological Oncology` by the American Radium
Society in February 1995. Presented at the Annual meeting of the American Radium Society, 2 nd May 1995
in Paris, France.
Awarded the `Lindsay Park Memorial Medal` for the best presentation at the meeting of the Birmingham &
Midland Obstetrics and Gynaecology Society, 5th May 1995.
Awarded a travelling bursary by the British Congress of Obstetrics and Gynaecology to support my
attendance for oral presentation at the meeting in Dublin, Ireland on the 5th July 1995.
PUBLICATIONS:
1) Herod J.J.O. and Johns E.J. (1985)
The influence of diltiazem and nifedipine on the haemodynamic and tubular responses of the rat kidney to
renal nerve stimulation.
Journal of Autonomic Pharmacology 5: pp 251-260
2) Beevers D, Beevers M, Zezulka A.V, Hornby R. and Herod J.J.O. (1987)
Standards for blood pressure measuring devices.
British Medical Journal. 294: p1614.
3) Herod J.J.O, Shafi M, and Watts J.Ff. (1994)
Ruptured uterus during middle trimester abortion with Gemeprost.
Journal of Obstetrics and Gynaecology 14: pp321-322
4) Herod J.J.O, Kerr D.J. and Luesley D.M. (1995)
Mechanisms of resistance to platinum chemotherapeutic agents.
Contemporary Reviews in Obstetrics and Gynaecology. Vol 7(1) p1-4.
5) Eliopoulos A.G, Kerr D.J, Herod J.J.O, Hodgkins L, Krajewski S, Reed, J.C. and Young L.S (1995).
The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2.
Oncogene 11: 1217-1228
6) Herod J.J.O, Shafi M.I, Jordan J.A, Rollason T.P. and Luesley D.M. (1996)
Vulvar Intraepithelial Neoplasia: Long-term follow-up of treated and untreated women.
British Journal of Obstetrics and Gynaecology No5 Vol103: pp453-456
7) Herod J.J.O, Shafi M.I, Jordan J.A, Rollason T.P. and Luesley D.M. (1996)
Vulvar intraepithelial neoplasia with superficially invasive carcinoma.
British Journal of Obstetrics and Gynaecology No5 Voll03: pp446-452
8) Herod J.J.O, Eliopoulos A.G, Young L.S, Niedobitek G, Warwick J. and Kerr D.J. (1996)
Prognostic significance of Bcl-2 and P53 expression in ovarian cancer.
Cancer Research Vol 56: pp2178-2184
9) Kehoe S, Herod J.J.O, van Geene P, Shafi M.I, Redman C.W.E, Luesley D.M. and Chan K.K. (1996)
Intentional non-radical surgery and survival in advanced ovarian cancer: results of a pilot study.
International Journal of Gynaecological Oncology No 6: pp448-451
10) Herod J.J.O, Warwick J, Chan K.K. and Luesley D.M, (1996)
Long-term survival following differing modes of treatment for ovarian cancer.
Accepted for publication in Clinical Oncology.
11) Clarke T.J, Herod J.J.O, Kehoe S. & Luesley D. M. (1999)
The development of invasive vulvar cancer in a patient with job's syndrome, a rare immunodeficient
condition
British Journal Of Obstetrics and Gynaecology Vol 105: 4 pp468-470
12) Herod J.J.O. and Shepherd J.H. (2000)
Radical Trachelectomy
Current Obstetrics and Gynaecology Vol 10: No1. pp37-41.
13) Herod J.J.O, Kehoe S, Poole C.J, Earl H, Luesley D.M, Jordan S, Warwick J. and Redman C.W.E.
A phase II Trial of Megestrol acetate and Oral Melphalan in patients unfit for platinum-based
chemotherapy with Advanced Epithelial Ovarian Cancer.
Accepted for publication in British Journal of Cancer.
14) Herod J, Burton A, Buxton J, Tobias J, Luesley D, Jordan S, Dunn J, Poole CJ. (2000)
A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP)
chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix.
Ann Oncol. 2000 Sep;11(9):1175-81
15) Kolomainen D and Herod J.J.O. (2001) – Hormone replacement therapy following breast and
gynaecological cancer.
The Obstetrician and Gynaecologist Vol3: No4 pp168-172
16) Kirwan JMJ, Tincello DG, Herod JJO, Frost F and Kingston RE. (2002)
Effects of delays in primary care referral on survival of women with epithelial ovarian cancer:
retrospective audit
British Medical Journal Vol 324: pp148-151
17) Kirwan J and Herod J.J.O. (2002)
Pre-invasive disease of the vulva
Current Obstetrics and Gynaecology Vol12;No2: pp90-96
18) Aust T, Kirwan J, Herod J and McVicker J. (2003)
Perforation With Gynefix Intrauterine Implant: Is There A Common Factor?
British Journal of Family Planning July 2003
19) Kolomainen DF, Herod JJO, Holland N and Shepherd JH. (2003)
Actinomyces on a papanicolaou smear following a radical trachelectomy.
Accepted for publication in British Journal of Obstetrics and Gynaecology
20) El-gobashy AA, Shaaban AM, Herod J, Innes J, Prime W and Herrington CS (2004)
Overexpression of cyclinc A and B as markers of neoplastic glandular lesions of the cervix.
Gynecologic Oncology in press
21) Kirwan JM, Herrington CS, Smith PA, Turnbull LS and Herod JJO (2004)
A retrospective clinical audit of cervical smears reported as 'glandular neoplasia'.
Cytopathology. 2004 Aug;15(4):188-94
CHAPTERS:
1) Herod J.J.O, & Luesley D.M. (1997) - Vulvar Intraepithelial Neoplasia
The Yearbook of Obstetrics and Gynaeclogy. Volume 5. pp175-188. 1997 ed Shaughn O`Brien. RCOG
press
2) Herod J.J.O, Hodgett S. & O`Brien P.M.S. (1997) - Introductory chapter – Hysterectomy and HRT.
Hysterectomy and HRT. pp1-16 eds L. Edwards & J. Studd, RCOG press.
3) Herod J.J.O. (1997) – Survey of Training by National Trainees Committee. Report and Results.
Royal College of Obstetricians and Gynaecologists, November 1997.
4) Herod J.J.O. & Luesley D.M. (1999) - Vaginal Cancer.
The Yearbook of Obstetrics and Gynaecology. Volume 7. pp136-148. 1999 ed P.M.S. O`Brien. RCOG press
5) Herod J.J.O. (1999) - How to prepare a thesis
Introduction to Research methodology for Specialists and Trainees. Pp241-247. eds P.M.S. O`Brien and F.
Broughton Pipkin. RCOG press
6) Herod J.J.O. and Shepherd J.H. (2000) – Reconstructive Surgery in the management of vulvar cancer
Cancer and Pre-cancer of the Vulva. Pp142-151 Ed Luesley D.M.
7) Herod J.J.O. and Gore M.E. (2000) – Pelvic mass in a woman over 40 years
Clinical Management of Ovarian Cancer. pp1-10. Eds Lederman J.A, Hoskins W.J, Kaye S.B. and Vergote
I.B. Martin Dunitz Ltd, London
8) Herod J.J.O. (2001) – Vaginal Cancer
Handbook of Gynaecological Oncology pp 187-199. Ed Shafi M.I.
9) Kirwan J.M.J. and Herod J.J.O. (2002) Vulval Cancer: Reconstructive Surgery.
RCOG DIALOG 4(1). RCOG, London.
10) Herod JJO (2003) - Strategies for decreasing the interval between presentation to the general
practitioner and referral to specialist hospital care
The Effective Management of Ovarian Cancer (third edition) – UK Key advances in clinical practice series.
Eds Kehoe S, Gore M and Miles A.
ABSTRACTS:
1) Herod J.J.O, Young L.S, Niedobitek G, Luesley D.M. and Kerr D.J. (1994)
Bcl-2 Protein in Ovarian carcinoma.
British Journal of Obstetrics and Gynaecology Vol 101, No 9 pp813.
2) Herod J.J.O, Shafi M.I, Luesley D.M, Jordan J.A. and Rollason T.P.R. (1994)
Conservative management of VIN.
International Journal of Gynaecology and Obstetrics. Vol 46 (suppl. 2) pp 116.
3) Herod J.J.O, Eliopoulos A.G, Ferry D and Kerr D.J. (1995)
Inhibition of A2780 Ovarian Carcinoma Cell Line by Quercetin and Cis-Platinum in vitro.
British Journal of Obstetrics and Gynaecology No 12 Vol 102: pp999
4) Herod J.J.O, Warwick J, Luesley D.M and Chan K.K. (1995)
Survival following differing modes of treatment for ovarian cancer
Proceedings of the American Radium Society -28th April - 2nd May 1995
5) Herod J.J.O, Kehoe S, van Geene P, Shafi M.I, Redman C.W.E, Chan K.K. and
Luesley D.M. (1995)
Survival in patients with advanced ovarian cancer and bulky residual disease
Proceedings of the British Gynaecological Cancer Society - 19-20TH May 1995
6) Herod J.J.O, Elipoulos A.G, Ferry D. And Kerr D.J.
Inhibition of A2780 Ovarian Carcinoma Cell Line by Quercetin and Cis-Platinum in vitro
British Journal of Obstetrics & Gynaecology Vol 102(12): p999
7) Herod J.J.O, Kehoe S, van Geene P, Shafi M.I, Redman C.W.E. Chan K.K. and Luesley D.M. (1995)
Survival in patients with advanced ovarian cancer and bulky residual disease
Proceedings of the British Congress of O & G 1995: abstract 11
8) Herod J.J.O, Kehoe, van Geene P, Shafi M.I, Redman C.W.E, Chan K.K. and Luesley D.M. (1995)
Survival in patients with advanced ovarian cancer and bulky residual disease
British Journal of Cancer; Vol 72: Supplement XXV, pp20
9) Eliopoulos A.G, Herod J.J.O, Hodgkins L, Reed J.C, Kerr D.J, and Young L.S. (1995)
Bcl-2 and p53 modulate apoptosis and drug resistance in Ovarian cancer
Proceedings of the 1st World Congress on Advances in Oncology Oct 22-26, Athens, Greece
10) Herod J.J.O, Shafi M.I, Luesley D.M, Jordan J.A. and Rollason T.P. (1995)
Vulvar Intraepithelial Neoplasia with Superficially Invasive Carcinoma Management and outcome
International Journal of Gynaecological Cancer. Vol 5, Suppl l p69
11) Herod J.J.O, Kehoe S, Warwick J, Poole C.J, Earle H.M. Luesley D.M, Jordan S.D. & Redman
C.W.E. (1996)
A phase II randomise study of megestrol acetate and oral mephalan in patients
(unfit for platinum-based chemotherapy) with advanced ovarian cancer.
British Journal of Obstetrics & Gynaecology Vol 103 (6): p589
12) Poole C.J, Perren T.J, Jordan S.D, Jemkins A.H, Herod J.J.O, Burton A, Mould J.J.
Spooner D.A, Luesley D. & Earl H.M. (1997)
Sequential Paclitaxel and Cisplatin chemotherapy in patients with newly diagnosed epithelial ovarian
cancer
Accepted for publication in the Journal of Clinical Oncology
13) JJO Herod, R Singh, E Moskovic, G Brown, JM Thomas, JH Shepherd and DPJ Barton (1999)
A comparison of pre-operative assessment of vulvar cancer using CT scanning or ultrasonography with fine
needle aspiration
British Journal of Obstetrics and Gynaecology Vol 106:9 p992
PRESENTATIONS AND POSTER DEMONSTRATIONS:
¥ = International presentation
1) Expression of bcl-2 protein in ovarian carcinoma - Poster demonstration
British Gynaecological Cancer Society Meeting
April 30th 1994, Glasgow U.K.
¥
2) Conservative management of VIN - Oral presentation
FIGO World Conference
September 29th 1994, Montreal Canada
3) Maternal awareness of Listeriosis in pregnancy - Oral presentation
Birmingham and Midland Obstetrics and Gynaecological Society
October 7th 1994 - Postgraduate Centre, Dudley Road Hospital, Birmingham U.K.
4) Inhibition of the A2780 ovarian carcinoma cell line by Quercetin and Cis-Platinum in vitro
Oral presentation
Blair Bell Research Society
3rd February 1995 - Royal College of Obstetricians and Gynaecologists, London
¥
5) Survival following differing modes of treatment for ovarian carcinoma -Oral presentation
Annual meeting of the American Radium Society
2nd May 1995 - Hotel Intercontinental, Paris, France
6)Conservative Management of VIN - Oral presentation
Birmingham and Midland Obstetrics and Gynaecological Society
5th May 1995 - Postgraduate Centre, Queen Elizabeth Hospital, Birmingham
7) Survival in patients with advanced ovarian carcinoma and bulky residual disease - Oral
presentation
Meeting of the British Gynaecological Cancer Society
20th May 1995, Conference Centre, Aberdeen
8) Inhibition of the A2780 Ovarian carcinoma cell line by Quercetin and Cis-Platinum in vitro Poster demonstration
Meeting of the British Gynaecological Cancer Society
20th May 1995, Conference Centre, Aberdeen
¥
9) Survival in patients with advanced ovarian carcinoma and bulky residual disease - Oral
presentation
British Congress of Obstetrics and Gynaecology
5th July 1995, Trinity College, Dublin, Ireland
10) Survival in patients with advanced ovarian carcinoma and bulky residual disease - Oral
presentation
Joint meeting of British Oncological Association and British Association of Surgical Oncology
University of York, 11th July 1995
¥
11) Vulvar Intraepithelial Neoplasia with Superficially Invasive Carcinoma - Poster presentation
5th biennial meeting of the International Gynaecolgical Cancer Society
September 4-8, 1995, Philadelphia, Pennsylvania, USA
12) Survival in patients with advanced ovarian carcinoma and bulky residual disease – Poster
presentation
Birmingham and Midland Obstetrics and Gynaecological Society, 6 th October 1995
Birmingham U.K.
13) A Phase II Randomised Trial of Megestrol acetate and Oral Melphalan in patients with
Advanced Epithelial Ovarian Cancer - Oral presentation
British Gynaecological Cancer Society, 4th November 1995
The Grand Hotel, Eastbourne
14) Prognostic significance of Bcl-2 and p53 in ovarian carcinoma - Oral presentation
Combined research meeting of academic unit of Obst & Gynae, Birmingham
University of Birmingham, 17th December 1995
¥
15) Vulvar Intraepithelial Neoplasia with superficially invasive carcinoma - Management and
Outcome - Oral presentation
British Society for Colposcopy and Cervical pathology
April 20th, Keele University conference Centre, Staffs, UK
¥
16) Bleomycin, ifosfamide and cis-platin in inoperable cancer of the cervix -Oral presentation
10th International meeting of the European Society of Gynaecological - Oncology
Coimbra, Portugal April 28th 1997
17) Bleomycin, ifosfamide and cis-platin in inoperable cancer of the cervix - Oral presentation
Birmingham & Midland Obstetrical & Gynaecological Society
Stafford General Hospital - 2nd May 1997
18) A comparison of pre-operative assessment of vulvar cancer using CT scanning or ultrasonography
with fine needle aspiration – Oral presentation
British Gynaecological Cancer Society, May 1999
Liverpool Maritime Museum, Liverpool
19) Liverpool Women’s Hospital Colposcopy System Development – Oral presentation
MUSE UK conference June 12th 2000
Goodison Park Football Ground, Liverpool
20) Evaluation of a risk of malignancy index in ovarian cancer – Poster demonstration
R.D. Athavale, J.J.O. Herod, P.K.V. Chia and R.E. Hopkins
British Gynaecological Cancer Society Annual Meeting – London Nov 2001
21) Effects of delays in primary care referral on survival of women with epithelial ovarian
cancer – Poster demonstration
John M Kirwan, Douglas G Tincello, J Jonathan O Herod, Olive Frost and Robert E
Kingston
British Gynaecological Cancer Society Annual Meeting – London Nov 2001
INVITED LECTURES:
1) Problems with the BIP Cervical cancer trials in Birmingham.
Joint meeting on Cervical Cancer. Depts of Gynaecology & Oncology
19th March 1994. The City Hospital, Nottingham
2) Can flagging trials be resuscitated? - Oral presentation
British Oncology Data Managers Association Annual Meeting
September 8th 1994, Birmingham U.K.
¥ 3) Training in the United Kingdom - Oral presentation
Ordem dos Medicos (Portuguese Medical Association)
25th November 1994, Lisbon, Portugal
4) Chemotherapy for Ovarian Cancer - Oral presentation
Adult Oncology Course - Birmingham Oncology Project
Queen Elizabeth Hospital, Birmingham, UK
5) Management of Epithelial Ovarian Cancer - oral presentation
Adult Oncology course - Birmingham Oncology Project
Queen Elizabeth Hospital, Birmingham, U.K.
6) The Management of Ovarian Carcinoma - Oral presentation
Part II MRCOG Course - Birmingham Women’s Health Care NHS Trust
July 15th 1995, Birmingham and Midland Hospital for Women
7) The Management of Ovarian Carcinoma - Oral presentation
Part II MRCOG Course - Birmingham Women’s Health Care NHS Trust
January 25th, 1996, The Birmingham Women’s Hospital
8) Advances in the management of Ovarian Cancer - Oral presentation
Part II MRCOG Course - Birmingham Women’s Health Care NHS Trust
July 4th, 1996, The Birmingham Women’s Hospital
9) The Diagnosis and Management of Intraepithelial Neoplasia
Part II MRCOG revision course - Royal College of Obst. & Gynaecologists
July 18th 1996, January 16th 1997 and July 12th 1997 - Royal College of Obstetricians and Gynaecologists,
London
10) Cervical Screening
DRCOG preparation course - North Staffordshire Hospital NHS Trust
4th March 1997, - Postgraduate Medical Education Centre – North Staffordshire Hospital
11) Screening in pregnancy
DRCOG preparation course - North Staffordshire Hospital NHS Trust
5th March 1997 - Postgraduate Medical Education Centre – North Staffordshire Hospital
12) Problems associated with the inadequately or incorrectly repaired perineum
Perineal repair study day
20th March 1997 - North Staffordshire Maternity Hospital
13) Trainees` view: results of the survey of training
An Open Manpower Meeting - What’s in a name? What’s in a number?
11th April 1997, Royal College of Obstetricians & Gynaecologists
14) Bleomycin, ifosfamide and cis-platin in inoperable cancer of the cervix - The Birmingham experience
MRC Gynaecological Cancer Planning Group
2nd June 1997 -. Royal Society of Medicine, London.
15) Menstrual Disorders
University of Keele Study day on “Women’s Health Problems”
12th June 1997 - North Staffordshire Hospital. Newcastle-under-Lyme, Staffordshire
16) Superficially invasive carcinoma of the vulva.
“Controversies in Colposcopy”
9th September 1997 - Royal College of Obstetricians & Gynaecologists, London
17) Epidemiology of Cervical Cancer
Oncology course for Nurses
17th October 1997 – St Bartholomew’s School of Nursing and Midwifery, London
18) The Biology and Genetics of Ovarian Cancer
North Thames Region Postgraduate Oncology Course
20th November 1997 – Royal College of Radiotherapists, London
19) The Management of Cervical Cancer
Women’s Health Screening Unit
12th January 1998 – City University London
20) The Principles of Gynaecological Surgery
ENB Theatre and Anaesthetic Course
20th April 1998 – St Bartholomew’s School of Nursing and Midwifery, London
21) Cervical Screening and the Management of Cervical Cancer
Women’s Health Screening Unit
7th July 1998 – City University, London
22) Current / Proposed Surgical Trials in Gynaecological Oncology
Mersey Region Gynaecological Oncology Research Group
Clatterbridge Centre for Oncology 13/1/00
23) A Randomised Phase III Trial to Evaluate the Usefulness of Pelvic Drains after Radical Hysterectomy
and Node Dissection
Mersey Region Gynaecological Oncology Research Group
Clatterbridge Centre for Oncology 2/3/00
24) Hormone Replacement Therapy and Gynaecological Cancer
Expert speaker meeting – Liverpool General Practitioners 13/4/00
25) Screening for Ovarian Cancer
Gynaecological Cancer Study Day 12/5/00
Clatterbridge Centre for Oncology, Postgraduate Education Centre
26) Surgery for Gynaecological Malignancy
Gynaecological Cancer Study Day 12/5/00
Clatterbridge Centre for Oncology, Postgraduate Education Centre
27) Screening for Ovarian Cancer
Postgraduate General Practitioner Meeting 13/5/00
Southport Hospital Postgraduate Education Centre
28) Screening for Ovarian Cancer
North-West Society of Family Planning and Sexual Medicine 3/3/01
Liverpool Maritime Museum
29) Cervical Cancer for the MRCOG
RCOG Part 2 MRCOG examination course – 5/7/01
Royal College of Obstetricians and Gynaecologists
30) Management of the Abnormal Smear and Cervical Cancer in Pregnancy
Genito-Urinary Physicians Colposcopy Group – Annual Scientific Meeting, 10th Nov 2001
Craxton Wood Hotel, South Wirral
31) Gynaecological Oncology for the MRCOG
RCOG Part 2 MRCOG examination course – 11/1/02
Royal College of Obstetricians and Gynaecologists
POSITIONS HELD
Representative of Junior Medical Staff on Dudley Road Hospital Antenatal Management
Committee - (1993)
Treasurer of the West Midlands regional trainees committee, representing junior doctors
training in Obstetrics and Gynaecology - (1994)
Chairman of West Midlands regional trainees committee - (1995 - 1996)
Member of National Trainees Committee (RCOG) - (1995-1996)
Junior Representative on West Midlands Higher Training Committee - (1995-1996)
Medical Staff representative on the Breast feeding committee - (1996)
The City Hospital, Dudley Road, Birmingham
Honorary Clinical Lecturer – Keele University – 1997
Honorary Clinical Lecturer – St Bartholomew’s and the Royal London Hospitals 1997-8
Honorary Clinical Lecturer – University of Liverpool – 2000 – present day
Members representative - Birmingham and Midland Obstetrics and Gynaecology Society (1997)
Member of Advisory Board – Ovacome (ovarian cancer charity) – 1999 – present day
Lead Clinician for Colposcopy – Liverpool Women’s Hospital – 1999 – present day
Member of Liverpool Cervical Cytology Working Party 1999 – 2001
Member of Colposcopy sub-group of Liverpool Cervical Cytology Working Party 1999 – 2001
Member of Colposcopy Specialist sub-group of North West Cervical Screening Quality Assurance
Reference Centre – 1999 – present day
Member of UK Physicians Advisory Group (Meditech) – 1999 – present day
Honorary Local Secretary (Liverpool) – North of England Obstetrical and Gynaecological Society – 1999present day
Clinical Sub-Dean – Liverpool, Women’s Hospital/University of Liverpool Medical School – 2000 – 2003
Member of Liverpool Cancer Resource Store Advisory Team – 2000 – 2004
Member of Joint Liverpool & Sefton Cervical Screening Working Group – 2001 – present day
Organiser of British Surgical Gynaecological Oncological Group – 2001 – present day
Member of International Editorial Advisory Board – Obs and Gynae Today 2001 – present day
Member of Liverpool Research Ethics Committee – 2002 – 2005
Lead Clinician – Liverpool Centre for United Kingdom Collaborative Trial of Ovarian Cancer
Screening(UKCTOCS) – 2000 – present day
Lead Clinician for Clinical Governance (Gynaecology) – Liverpool Women’s Hospital – 2002 – 2005
Spokesperson for RCOG on Gynaecological Oncology 2005 – present day
I am regularly asked to review papers and applications related to gynaecological oncology submitted to
British Journal of Obstetrics & Gynaecology
International Journal of Gynaecological Cancer
WellBeing research Grant application reviews (RCOG)
Cochrane Gynaecological Cancer Collaborative Review Group
Sessional doctor at BPAS Liverpool Jan 2004 – Sept 2005